The ApiFix Minimally Invasive Deformity Correction (MID-C) technology for correction of Adolescent Idiopathic Scoliosis has been used in 250 patients to date.
Trice Medical launched mi-ultra, a high-powered handheld ultrasound transducer optimized for musculoskeletal applications for use at the first point of care.
The U.K.'s National Institute for Health and Care Excellence published medical technology guidance recommending SI-BONE's iFuse® for the treatment of chronic sacroiliac joint pain.
Amedica completed the sale of its spine business to CTL Medical, which is now exclusive owner of the metal and silicon nitride spine product portfolio.
Bioventus received ANVISA approval to market DUROLANE® single-injection in Brazil to treat hip osteoarthritis. Pfizer will serve as its exclusive distribution partner.
aap Implantate will receive federal funding in Germany to pursue human clinical study of antibacterial silver coating technology that may inhibit bacterial growth on the surface of an implant.